Research programme: thymus induced pluripotent stem cell (iPSC)-based cell therapies - Tolerance Bio
Alternative Names: allogenic thymus induced pluripotent stem cell (iPSC)-based cell therapies - Tolerance Bio; thymus induced pluripotent stem cell (iPSC)-based cell therapies - Tolerance BioLatest Information Update: 03 Dec 2024
Price :
$50 *
At a glance
- Originator Tolerance Bio
- Class Induced pluripotent stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Immunological disorders